D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway.
Neurophysiological techniques were used to examine the possibility that the effects of bromocriptine, a direct acting dopamine agonist, can be potentiated by D-1 receptor stimulation in an animal model of parkinsonism. Single unit activity of substantia nigra pars reticulata neurons was recorded in rats with 6-hydroxydopamine induced lesions of the nigrostriatal pathway. The results showed that the coadministration of bromocriptine with the selective D-1 agonist SKF 38393 greatly attenuated pars reticulata neuronal activity at doses that did not produce significant effects when administered alone. Thus, processes elicited by D-1 receptor stimulation and bromocriptine exert synergistic effects in these 6-hydroxydopamine lesioned rats. This observation may be relevant to the mechanism underlying l-DOPA's ability to potentiate the therapeutic effects of bromocriptine in parkinsonian patients.